Endometrial myomectomy

a novel surgical method during cesarean section

Şafak Hatırnaz, Oğuz Güler, Serdar Başaranoğlu, Cengiz Tokgöz, Gokhan Kilic

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Study objective: Comparing surgical outcomes of a novel surgical technique endometrial myomectomy (EM) to serosal myomectomy (SM) during ceserean section (CS). Design: Retrospective cohort study (Canadian task force classification level II 1). Setting: Private hospital. Patients: Fourty-six women with leiomyomas during cesarean section Interventions: Endometrial myomectomy and serosal myomectomy during cesarean section between 2013 and 2016. Main outcome measures: Total 22 consequtive cases (Group 1) underwent EM in the last 2 years. The control group created from SM (Group 2) cases performed before EM implemented in our practice. Group 2 was matched based on anteriorly located intramural or submucosal leiomyoma. The size, location and number of leiomyoma, hematological course during pre- and postoperative period, the need for blood transfusion, duration of surgery, and any prolongation of hospital stay also documented. Results: Median number of leiomyoma was higher in EM than in SM (p = 0.001). Median myomectomy procedure time and amount of intra-operative bleeding in SM were higher than EM (respectively, p = 0.005 and p = 0.001). In terms of other variables, there is no difference between the two myomectomy groups (p > 0.05). Conclusion: This novel technique EM is a safe, feasible surgical technique compared with SM. Besides the less intra-operative blood loss, it also has the potential to diminish the risk of abdominal adhesion formation.

Original languageEnglish (US)
Pages (from-to)1-6
Number of pages6
JournalJournal of Maternal-Fetal and Neonatal Medicine
DOIs
StateAccepted/In press - Feb 9 2017

Fingerprint

Uterine Myomectomy
Cesarean Section
Leiomyoma

Keywords

  • adhesion formation
  • Cesarean section
  • endometrial myomectomy
  • leiomyoma
  • serosal myomectomy

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Endometrial myomectomy : a novel surgical method during cesarean section. / Hatırnaz, Şafak; Güler, Oğuz; Başaranoğlu, Serdar; Tokgöz, Cengiz; Kilic, Gokhan.

In: Journal of Maternal-Fetal and Neonatal Medicine, 09.02.2017, p. 1-6.

Research output: Contribution to journalArticle

Hatırnaz, Şafak ; Güler, Oğuz ; Başaranoğlu, Serdar ; Tokgöz, Cengiz ; Kilic, Gokhan. / Endometrial myomectomy : a novel surgical method during cesarean section. In: Journal of Maternal-Fetal and Neonatal Medicine. 2017 ; pp. 1-6.
@article{8ccd23229f074c9ab2dba999932fd2ae,
title = "Endometrial myomectomy: a novel surgical method during cesarean section",
abstract = "Study objective: Comparing surgical outcomes of a novel surgical technique endometrial myomectomy (EM) to serosal myomectomy (SM) during ceserean section (CS). Design: Retrospective cohort study (Canadian task force classification level II 1). Setting: Private hospital. Patients: Fourty-six women with leiomyomas during cesarean section Interventions: Endometrial myomectomy and serosal myomectomy during cesarean section between 2013 and 2016. Main outcome measures: Total 22 consequtive cases (Group 1) underwent EM in the last 2 years. The control group created from SM (Group 2) cases performed before EM implemented in our practice. Group 2 was matched based on anteriorly located intramural or submucosal leiomyoma. The size, location and number of leiomyoma, hematological course during pre- and postoperative period, the need for blood transfusion, duration of surgery, and any prolongation of hospital stay also documented. Results: Median number of leiomyoma was higher in EM than in SM (p = 0.001). Median myomectomy procedure time and amount of intra-operative bleeding in SM were higher than EM (respectively, p = 0.005 and p = 0.001). In terms of other variables, there is no difference between the two myomectomy groups (p > 0.05). Conclusion: This novel technique EM is a safe, feasible surgical technique compared with SM. Besides the less intra-operative blood loss, it also has the potential to diminish the risk of abdominal adhesion formation.",
keywords = "adhesion formation, Cesarean section, endometrial myomectomy, leiomyoma, serosal myomectomy",
author = "Şafak Hatırnaz and Oğuz G{\"u}ler and Serdar Başaranoğlu and Cengiz Tokg{\"o}z and Gokhan Kilic",
year = "2017",
month = "2",
day = "9",
doi = "10.1080/14767058.2017.1286320",
language = "English (US)",
pages = "1--6",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Endometrial myomectomy

T2 - a novel surgical method during cesarean section

AU - Hatırnaz, Şafak

AU - Güler, Oğuz

AU - Başaranoğlu, Serdar

AU - Tokgöz, Cengiz

AU - Kilic, Gokhan

PY - 2017/2/9

Y1 - 2017/2/9

N2 - Study objective: Comparing surgical outcomes of a novel surgical technique endometrial myomectomy (EM) to serosal myomectomy (SM) during ceserean section (CS). Design: Retrospective cohort study (Canadian task force classification level II 1). Setting: Private hospital. Patients: Fourty-six women with leiomyomas during cesarean section Interventions: Endometrial myomectomy and serosal myomectomy during cesarean section between 2013 and 2016. Main outcome measures: Total 22 consequtive cases (Group 1) underwent EM in the last 2 years. The control group created from SM (Group 2) cases performed before EM implemented in our practice. Group 2 was matched based on anteriorly located intramural or submucosal leiomyoma. The size, location and number of leiomyoma, hematological course during pre- and postoperative period, the need for blood transfusion, duration of surgery, and any prolongation of hospital stay also documented. Results: Median number of leiomyoma was higher in EM than in SM (p = 0.001). Median myomectomy procedure time and amount of intra-operative bleeding in SM were higher than EM (respectively, p = 0.005 and p = 0.001). In terms of other variables, there is no difference between the two myomectomy groups (p > 0.05). Conclusion: This novel technique EM is a safe, feasible surgical technique compared with SM. Besides the less intra-operative blood loss, it also has the potential to diminish the risk of abdominal adhesion formation.

AB - Study objective: Comparing surgical outcomes of a novel surgical technique endometrial myomectomy (EM) to serosal myomectomy (SM) during ceserean section (CS). Design: Retrospective cohort study (Canadian task force classification level II 1). Setting: Private hospital. Patients: Fourty-six women with leiomyomas during cesarean section Interventions: Endometrial myomectomy and serosal myomectomy during cesarean section between 2013 and 2016. Main outcome measures: Total 22 consequtive cases (Group 1) underwent EM in the last 2 years. The control group created from SM (Group 2) cases performed before EM implemented in our practice. Group 2 was matched based on anteriorly located intramural or submucosal leiomyoma. The size, location and number of leiomyoma, hematological course during pre- and postoperative period, the need for blood transfusion, duration of surgery, and any prolongation of hospital stay also documented. Results: Median number of leiomyoma was higher in EM than in SM (p = 0.001). Median myomectomy procedure time and amount of intra-operative bleeding in SM were higher than EM (respectively, p = 0.005 and p = 0.001). In terms of other variables, there is no difference between the two myomectomy groups (p > 0.05). Conclusion: This novel technique EM is a safe, feasible surgical technique compared with SM. Besides the less intra-operative blood loss, it also has the potential to diminish the risk of abdominal adhesion formation.

KW - adhesion formation

KW - Cesarean section

KW - endometrial myomectomy

KW - leiomyoma

KW - serosal myomectomy

UR - http://www.scopus.com/inward/record.url?scp=85012049349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85012049349&partnerID=8YFLogxK

U2 - 10.1080/14767058.2017.1286320

DO - 10.1080/14767058.2017.1286320

M3 - Article

SP - 1

EP - 6

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

ER -